跳至主要内容
临床试验/NCT07657117
NCT07657117尚未招募不适用

Ambulance Stroke Triage Assisted by Telemedicine (ASTRAL) Trial.

NyikaKruyt1 个研究点 分布在 1 个国家目标入组 484 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
484
试验地点
1

研究概览

简要总结

The ASTRAL trial is a randomized study in patients with suspected stroke in the ambulance setting. The study evaluates whether prehospital telestroke consultation, in addition to standard care, can reduce unnecessary stroke code activations and improve patient triage, treatment efficiency, and resource use. Participants are randomized to telestroke triage plus standard care or standard care alone. Outcomes include unnecessary stroke code activation, patient allocation, treatment times, functional outcome, safety, and cost-effectiveness.

详细描述

The Ambulance Stroke Triage Assisted by Telemedicine (ASTRAL) trial is a prospective, randomized controlled trial in suspected stroke patients attended by ambulance professionals in the RAV Hollands Midden region. Patients aged 18 years or older with stroke code activation during office hours and symptom onset within 24 hours are randomized 1:1 to telestroke triage plus standard care or standard care alone. The intervention consists of real-time video and audio consultation with an on-duty neurologist who advises on stroke probability, destination, and urgency of transport, while ambulance professionals retain final decision authority. The primary endpoint is unnecessary stroke code activation. Secondary endpoints include allocation accuracy, safety, door-to-needle and door-to-groin times, modified Rankin Scale at 3 months, health-related quality of life, healthcare utilization, stakeholder satisfaction, and cost-effectiveness. Outcome assessors for 3-month follow-up measures are blinded to allocation. Data are collected in Castor EDC, and analyses follow the intention-to-treat principle

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

The study is open-label for participants, ambulance professionals, and treating neurologists. Outcomes assessors for 3-month mRS and EQ-5D-5L assessments are blinded to treatment allocation

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Stroke code activation by ambulance professional during office hours
  • Symptom onset < 24 hours or uncertain onset
  • The patient is deemed capable of understanding the study information and making a decision about participation/opt-out

排除标准

  • - Age under 18 years

研究组 & 干预措施

Telestroke Triage + Standard Care

Experimental

Ambulance professionals receive real-time neurologist consultation via the SMART Triage platform in addition to standard prehospital stroke care.

干预措施: Telestroke triage (Other)

Standard Care

Active Comparator

RAV Hollands Midden triage protocol without telestroke consultation.

干预措施: Standard Care (in control arm) (Other)

研究者

发起方
NyikaKruyt
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

NyikaKruyt

Principal Investigator

Leiden University Medical Center

研究点 (1)

Loading locations...

相似试验